32303
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Goodbye all. I am out of this at a big loss. Owning this has been a nightmare. I will never buy into an Israeli company again.
Outlook bleak on planet Earth.
PSTI toilet backs up
very sad to watch others rise
The only gift of Mexico is the 2-step.
Losses build character which is why there are a lot of characters out there.
Nothing comes of nothing.
They are a poor performer.
Nothing comes of nothing.
Trust Is the lost commodity.
Trust Is the lost commodity.
Exactly.
Now that COVID has a slew of preventives and treatments and cells are not foreseeable the whole company and its competition have settled into innocuous desuetude, trapped like rodents on a raft.
The question that is currently on my to ask list is whether the cannibis patents can be sold and whether the 3D kettles may be of some use to loan to the Salvation Army. When is the yard sale?
The toilet handle controls the level of the tank.
Execrable performance.
There is nothing in Mexico; the upper classes are the only ones that can afford any kind of treatment. PSTI has sunk to the lowest depths. What a joke, how pathetic. They would probably be more likely to make a few dollars offering colonoscopies. Their management is so pathetic. They are grasping at straws.
Nauseated by PSTI performance.
What are chances of good news?
Sharks circle the raft.
Lower the lifeboats.
Once more the shorts are prescient. Too bad there is yet no product. Is any news expected from clinical trials at some point in the future or are they looking into other venues of research now that the promise has lost its gloss amid the various and sundry efforts by companies to implement a major stem cell push? I still want a mousepad if they go under, probably by the end of the year. It’s bleak at the end of the tunnel. Have a bowl of cold gruel and pray.
The question as to type of stem cell is not as vital as many companies can alter them. The question seems to be whether they are efficient and effective to the satisfaction of the FDA. There are so many remedies including newer ones that the market is saturated. Too many medications have overmodulated disease. Expense of drugs has risen in some situations making healing too expensive. Many people who are on medication are despondent or plagued with other problems like obesity. It is time to take a new look at where industrial solutions can be used for overriding problems rather than the boutique approach that drives up cost.
Debacle.
Nothing is going to work out until next year. I have my fingers crossed.
Keep hope alive.
I think that is a lot of coffee. No wonder they are up tight. Where is their product, if any?
Sadly so.
Sadly so.
There is no carrot at the end of this tunnel, no matter how thin you slice it.
Momentary only.
Of course they admit "Investing in our securities involves significant risks." Yes, especially when the company fails to support its own pps. Why did they post at $6.30 in new offering? The clue is that they, themselves, are have little confidence. Ask why they have never paid dividends and apparently reserve the right not to update their hopelessness-risk statements. Do they have a product or simply "potential" products. Like the Cheshire Cat in Alice in Wonderland, substance disappears and only a smile is left. I suggest, things being what they are, they shouldn't back up their own computers. It would be haphazard to leave anything around when the guillotine finally comes down. Brinkley's Goat Glands and Lydia Pinkham's Tonic! Yakov's Elixer!
Clover W will short out soon imho
Making money is the exception.
Well this would happen. This stock has become a POS, which everyone knew would happen after the CLI debacle and the FDA refusing to approve a Austrailan stem cell company's "product."
Metformin will be sold as "Nimroftem" under new Pluristem patent.
Shorts are knowledgeable. Thurs and Fridays history shows that pps falls after small gain Mon and Tues. On Wednesdays, some sell for small gains. This drives the price down for the weekend. It's a predictable pattern with PSTI. ARK, others ignore tremors as there are no signs that FDA will approve new stem cell products. Stem cells have gotten a bad name from the pseudo clinics and lawsuits. Furthermore, the patents are worth little in the scheme of things. Any company can challenge patents. Betting on a losing horse is not productive. I remember betting on a dog in Miami that dropped dead in the middle of the race.
Short is the only way to go.